Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for Blood Pressure Variability in Stage I Hypertension
NCT03592667Phase 4Unknown
- Sponsor
- Universidad de Guadalajara
- Start
- Feb 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in hypertension (HTN), sponsored by Universidad de Guadalajara. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03592667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03592667.